Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts

  • Sherrill L Macura1,
  • Jeremy L Steinbacher2,
  • Maximilian B MacPherson1,
  • Melissa J Lathrop3,
  • Mutlay Sayan1,
  • Jedd M Hillegass1,
  • Stacie L Beuschel1,
  • Timothy N Perkins1,
  • Page C Spiess1,
  • Albert van der Vliet1,
  • Kelly J Butnor1,
  • Arti Shukla1,
  • Marilyn Wadsworth1,
  • Christopher C Landry2 and
  • Brooke T Mossman1Email author
BMC Cancer201313:400

DOI: 10.1186/1471-2407-13-400

Received: 16 November 2012

Accepted: 2 August 2013

Published: 11 September 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
16 Nov 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Mar 2013 Reviewed Reviewer Report - Mirco Ponzoni
20 Mar 2013 Reviewed Reviewer Report - Penelope Ottewell
3 May 2013 Author responded Author comments - Brooke Mossman
Resubmission - Version 3
3 May 2013 Submitted Manuscript version 3
7 May 2013 Reviewed Reviewer Report - Mirco Ponzoni
14 May 2013 Reviewed Reviewer Report - Penelope Ottewell
10 Jun 2013 Author responded Author comments - Brooke Mossman
Resubmission - Version 4
10 Jun 2013 Submitted Manuscript version 4
17 Jul 2013 Author responded Author comments - Brooke Mossman
Resubmission - Version 5
17 Jul 2013 Submitted Manuscript version 5
Publishing
2 Aug 2013 Editorially accepted
11 Sep 2013 Article published 10.1186/1471-2407-13-400

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pathology, University of Vermont College of Medicine
(2)
Department of Chemistry, University of Vermont
(3)
Departments of Medicine, University of Vermont College of Medicine

Advertisement